【Conference presentation】Presenting the AD/PD™ 2024 International Conference on Alzheimer’s and Parkinson’s Diseases

Sysmex Corporation presented the latest data on the development of blood-based biomarkers for Alzheimer's Disease at Alzheimer's Disease Annual Meeting held from March 5^th to 9^th, 2024 in Lisbon, Portugal, " AD/PD™ 2024 International Conference on Alzheimer’s and Parkinson’s Diseases "

Session	Subject	Presenter (Affiliation)
On-Demand Oral VIRTUAL ORAL: THEME A (VO045 / #2859)*¹	High correlation of plasma tau and p-tau181 levels measured by a fully automated immunoassay system and an immunoprecipitation mass spectrometry assay Overview of presentation	Kengo Ishiki (Sysmex corporation)
On-Demand Oral VIRTUAL ORAL: THEME A (VO046 / #2860)^*2	Age dependency of blood-based biomarkers for AD measured by fully automated and highly specific immunoassays in general Japanese men: SESSA Overview of presentation	Kengo Ishiki (Sysmex corporation)
POSTER: THEME B (P0824 / #2855)*³	Increasing plasma Abeta42/40 accuracy by combining p-tau181 levels that are measured by fully automated immunoassay platform Overview of presentation	Kazuya Matsumoto (Sysmex corporation)
POSTER: THEME A (P0436 / #2772)*⁴	Performance of plasma Aβ42/40 ratio to predict Aβ pathology status defined by CSF testing in SPIN cohort Overview of presentation	Yuko Sasaki (Sysmex R&D Center Europe GmbH)

Terminology
*1Co-presentation with Eisai Co., Ltd.
*2Co-presentation with Shiga University of Medical Science
*3Co-presentation with Tokyo Metropolitan Institute for Geriatrics and Gerontology
*4Co-presentation with Hospital de la Santa Creu i Sant Pau, Spain

Information contained in the news and event is current as of the date of the announcement,
but may be subject to change without prior notice.

Back to "News / Event"